CureVac N.V.
CVAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $6 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $1 | $5 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 895.5% | -20.3% | -34.5% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 80.2% | -131.3% | -172.9% | -131.3% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 39.2% | -435.5% | -310.6% | -375.3% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 30.3% | -484% | -369.4% | -399.8% |
| EPS Diluted | 0.72 | -1.18 | -1.32 | -2.21 |
| % Growth | 161% | 10.6% | 40.3% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$1 |